click below
click below
Normal Size Small Size show me how
PHARM chp 1
| Term | Definition |
|---|---|
| adverse effects | drug effects that are not the desired therapeutic effects; may be unpleasant or even dangerous |
| brand name | name given to a drug by the pharmaceutical company that developed it; also called a trade name |
| chemical name | name that reflects the chemical structure of a drug |
| drugs | chemicals that are introduced into the body to bring about some sort of change |
| Food and Drug Administration (FDA) | federal agency responsible for the regulation and enforcement of drug evaluation and distribution policies |
| generic drugs | drugs sold by their generic name; not brand (or trade) name products |
| generic name | the original designation that a drug is given when the drug company that developed it applies for the approval process |
| genetic engineering | process of altering DNA, usually of bacteria, to produce a chemical to be used as a drug |
| orphan drugs | drugs that have been discovered but would not be profitable for a drug company to develop; usually drugs that would treat only a small number of people; these orphans can be adopted by drug companies to develop |
| over-the-counter (OTC) drugs | drugs that are available without a prescription for self-treatment of a variety of complaints; deemed to be safe when used as directed |
| pharmacology | the study of the biological effects of chemicals |
| pharmacotherapeutics | clinical pharmacology—the branch of pharmacology that deals with drugs; chemicals that are used in medicine for the treatment, prevention, and diagnosis of disease in humans |
| phase I study | a pilot study of a potential drug done with a small number of selected, healthy human volunteers |
| phase II study | a clinical study of a proposed drug by selected physicians using actual patients who have the disorder the drug is designed to treat; patients must provide informed consent |
| phase III study | use of a proposed drug on a wide scale in the clinical setting with patients who have the disease the drug is thought to treat |
| phase IV study | continual evaluation of a drug after it has been released for marketing |
| preclinical trials | initial trial of a chemical thought to have therapeutic potential; uses laboratory animals, not human subjects |
| teratogenic | having adverse effects on the fetus |
| Drugs | are chemicals that are introduced into the body to bring about some sort of change |
| Drugs can come from many sources | plants, animals, inorganic elements, and synthetic preparations |
| The FDA | regulates the development and marketing of drugs to ensure safety and efficacy |
| Preclinical trials | involve testing of potential drugs on laboratory animals to determine their therapeutic and adverse effects |
| Phase I studies | test potential drugs on healthy human subjects |
| Phase II studies | test potential drugs on patients who have the disease the drugs are designed to treat |
| Phase III studies | test drugs in the clinical setting to determine any unanticipated effects or lack of effectiveness |
| FDA | pregnancy categories indicate the potential or actual teratogenic effects of a drug |
| DEA | controlled-substance categories indicate the abuse potential and associated regulation of a drug |
| Generic drugs | are sold under their generic names, not brand names; they may be cheaper but in some situations are not necessarily as safe as brand-name drugs |
| Orphan drugs | are chemicals that have been discovered to have some therapeutic effect but that are not financially advantageous to develop into drugs |
| OTC drugs | are available without prescription for the self-treatment of various complaints |
| Information about drug sources | the drug label, reference books, journals, and Internet sites |